Skip to main content

For Healthcare Professionals

Site Menu

  • Press
  • About Us
  • Global Website
  • Contact
  • English

Search for product, molecule, disease…

User account menu

  • Log in
Home
  • Therapeutic Areas
    • CMR
  • Products
    • Jentadueto®
    • Trajenta®
  • Diseases
    • Diabetes
  • LogIn

Search for product, molecule, disease…

Prof. Frankel (London, UK)

  1. Boehringer Ingelheim
  2. HCP Portal
  3. Products
  4. Trajenta®
  5. Resources
  6. Prof. Frankel (London, UK)

Prof. Frankel (London, UK)

Published 14.08.2019 by Boehringer Ingelheim

Trajenta®’s convenience of 5mg once daily, for a broad range of people with T2D.

 
Transcript

Trajenta offers me, and indeed all physicians caring for people with diabetes, a convenient once daily treatment. Trajenta can be prescribed at 5 milligrams, once daily for the broad range of people with type 2 diabetes. And I would highlight that there is no requirement to undertake any additional monitoring over and above that which you would usually undertake in a person with diabetes. This adds to the simplicity when using Trajenta in primary care, which is important because of the significant pressure that primary care face with the growing burden of people with type 2 diabetes.

RELATED CONTENT

Video of Professor Cummings from the UK speaking about Trajenta
Prof. Cummings (Portsmouth, UK)

Simplicity of Trajenta® within the DPP4i class.

Video of Professor Cummings from the UK speaking about Trajenta
Prof. Cummings (Portsmouth, UK)

Trajenta® consistently lowers HbA1c.

Video of Professor Jodar from Spain speaking about Trajenta
Prof. Jodar (Madrid, Spain)

CARMELINA® is a unique CVOT in the DPP4i class.

Footer menu

  • Sitemap
  • Accessibility Statement
  • Terms of Use
  • Imprint
  • Cookie Policy
  • Privacy Policy
© 2022 Boehringer Ingelheim International GmbH. All rights reserved.
© 2022 Boehringer Ingelheim International GmbH.
All rights reserved.